Efficacy of Exercise on Physical Function and Cartilage Health in Patients With Knee Osteoarthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01682980|
Recruitment Status : Recruiting
First Posted : September 11, 2012
Last Update Posted : October 23, 2014
|Condition or disease||Intervention/treatment||Phase|
|Osteoarthritis Pain||Other: Strength training Other: Aerobic exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||207 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Efficacy of Strength and Aerobic Exercise on Patient-reported Outcomes and Structural Changes in Patients With Knee Osteoarthritis - A Randomised Controlled Trial.|
|Study Start Date :||March 2013|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2025|
Experimental: Strength training
The strength group include progressive strength training and neuromuscular exercises. The inclusion will be performed 2-3 times a week for 12 weeks.
Other: Strength training
The strength training will be delivered 2-3 times per week for 12 weeks, 5-8 repetitions maximum in 3 series. The patients must warm up 5 minutes on an ergometer cycle. The following muscle groups will be trained: Quadriceps and hamstrings, hip muscles (abductors and extensors), calf muscles. A home exercise program will be delivered including one leg exercises and balance exercises. Progression will follow a 2+ principle. For instance, when the study participant is able to perform 2 more repetitions, more loads are required.
Experimental: Aerobic exercise
The aerobic exercise group will cycle on an ergometer bicycle 2-3 times a week for 12 weeks on moderate loading. The loading will be controlled by a heart rate monitor and is defined as 75% of maximal heart rate (calculated with formula for maximal heart rate reserve).
Other: Aerobic exercise
The aerobic exercise program include ergometer cycling for at least 45 minutes 2-3 times a week on 75-80% of max heart rate will be required.
No Intervention: Control group
The control group will do as usual.
- Knee-related quality of life [ Time Frame: 1 year ]Primary outcome for the study will be the quality of life subscale of the Knee Injury and Osteoarthritis Outcome Score (KOOS) (0-100 scale).
- Knee function [ Time Frame: 1 year ]The KOOS is a self-administered knee-specific questionnaire containing 5-item Likert scales on pain, other symptoms, activities of daily living (ADL), function in sports and recreation and knee-related (QOL).
- Health-related quality of life [ Time Frame: 1 year ]
- Radiographic osteoarthritis progression [ Time Frame: 2 years ]Conventional x-rays will be used to assess radiographic progression of osteoarthritis
- Cartilage morphology measures (MRI) [ Time Frame: 1 year ]MRI techniques including T2 mapping and T1rho sequences.
- Isokinetic muscle strength [ Time Frame: 1 year ]
- Maximal oxygen consumption (VO2max) [ Time Frame: 1 year ]
- Self-efficacy for pain (ASES) [ Time Frame: 1 year ]
- Total knee replacement [ Time Frame: 5 years ]We will register continuously numbers of total knee replacements during the follow-up years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01682980
|Contact: Britt Elin Øiestad, PhD||+4792803089||Britt-Elin.Oiestad@hioa.no|
|Contact: May Arna Risberg, PhDfirstname.lastname@example.org|
|Oslo University Hospital||Recruiting|
|Oslo, Norway, 0407|
|Contact: Britt Elin Øiestad, PhD +4792803089 Britt-Elin.Oiestad@hioa.no|
|Principal Investigator: Britt Elin Øiestad, PhD|
|Sub-Investigator: May Arna Risberg, PhD|
|Study Chair:||May Arna Risberg, PhD||Oslo University Hospital|